-
Loading metrics
A Trial-Based Cost-Effectiveness Analysis of Erlotinib Alone versus Platinum-Based Doublet Chemotherapy as First-Line Therapy for Eastern Asian Nonsquamous Non–Small-Cell Lung Cancer
- Siying Wang,
- Liubao Peng,
- Jianhe Li,
- Xiaohui Zeng,
- Lihui Ouyang,
- Chongqing Tan,
- Qiong Lu
x
- Published: March 8, 2013
- https://doi.org/10.1371/journal.pone.0055917